| |
| |
|
| Insider
Information: |
Mojcik Christopher F |
| Relationship: |
SVP Clinical Development |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,152 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,582,740 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,152 |
|
|
| Total
Value |
$2,582,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
SVP Clinical Development |
2007-05-29 |
14,152 |
2005-03-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2007-05-29 |
4 |
S |
$47.02 |
$1,373,772 |
D/D |
(29,184) |
14,152 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2007-05-29 |
4 |
S |
$47.11 |
$236,634 |
D/D |
(5,023) |
43,336 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2007-05-29 |
4 |
S |
$47.12 |
$2,792,630 |
D/D |
(59,136) |
48,359 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2007-05-29 |
4 |
S |
$47.51 |
$503,279 |
D/D |
(10,532) |
107,505 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2007-05-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
103,875 |
118,027 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2007-03-12 |
4 |
AS |
$37.15 |
$21,138 |
D/D |
(569) |
14,152 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
14,721 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2006-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,721 |
11,721 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP Clinical Development |
• – – |
2006-01-09 |
4/A |
A |
$20.72 |
$103,600 |
D/D |
5,000 |
8,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
• – – |
2006-01-09 |
4 |
A |
$20.72 |
$62,160 |
D/D |
3,000 |
6,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP Clinical Development |
• – – |
2005-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
